Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Mar 1;169(3):1059-70.
doi: 10.1084/jem.169.3.1059.

Isolation and characterization of a B lymphocyte mutant with altered signal transduction through its antigen receptor

Affiliations

Isolation and characterization of a B lymphocyte mutant with altered signal transduction through its antigen receptor

J G Monroe et al. J Exp Med. .

Abstract

A receptor surface Ig (sIg) signaling variant of WEHI-231 was constructed to investigate components and linkages between various signaling events associated with signal transduction through sIg. Unlike the wildtype, crosslinking of sIgM on VS2.12-cl.2 did not result in downregulation of proliferation. Similarly, receptor crosslinking was uncoupled from inositol phospholipid (PI) hydrolysis and upregulation of c-fos expression in the variant. The signaling defect in VS2.12-cl.2 appears to be proximal to phospholipase C activation as direct G protein activation by A1F4- triggers PI hydrolysis and bypassing PI hydrolysis using phorbol diester stimulation of protein kinase C restores the inhibitable phenotype and the ability to upregulate c-fos. Even more interesting, sIg-linked Ca2+ responses by VS2.12-cl.2 are equivalent to these observed in the wildtype WEHI-231. These latter results suggest that contrary to current thought, sIg-generated signals may not be coupled to Ca2+ fluxes entirely via inositol phospholipid hydrolysis. Thus, VS2.12-cl.2 is a new and powerful tool with which to analyze signaling through sIg at the molecular level.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1982 Aug;79(16):4888-91 - PubMed
    1. J Immunol. 1981 Jun;126(6):2466-9 - PubMed
    1. J Immunol. 1984 Mar;132(3):1472-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5546-50 - PubMed
    1. J Immunol. 1984 Dec;133(6):3382-6 - PubMed

Publication types

MeSH terms